Discovery and Evaluation of 4-(2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyridin-2(1<i>H</i>)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity
Upender Velaparthi(Bristol-Myers Squibb (United States)), Dolatrai M. Vyas(Bristol-Myers Squibb (United States)), Karishma Patel(Bristol-Myers Squibb (United States)), Praveen Balimane(Bristol-Myers Squibb (United States)), Zheng Yang(Renmin Hospital of Wuhan University), Peiying Liu(Duke University), Wendy Clarke(Bristol-Myers Squibb (United States)), Marco M. Gottardis(Georgetown University), Lorell Discenza(Bristol-Myers Squibb (United States)), Mark G. Saulnier(Bristol-Myers Squibb (United States)), George L. Trainor(DuPont (United States)), Sean Kim(Bristol-Myers Squibb (Germany)), Ann Greer(Bristol-Myers Squibb (United States)), Michael Sinz(Rutgers, The State University of New Jersey), Francis Y. Lee(Yale University), Joan M. Carboni(Bristol-Myers Squibb (United States)), Aixin Li(University of South China), Kurt Zimmermann(Bristol-Myers Squibb (United States)), Mark D. Wittman(Bristol-Myers Squibb (United States)), Ricardo M. Attar(Johnson & Johnson (United States)), Warren Hurlburt(Bristol-Myers Squibb (United States))
Cited by 33
Related Papers
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
|Bioorganic & Medicinal Chemistry Letters|1998|406
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells
|Journal of Biological Chemistry|1994|327
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312